- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01875055
Reversing Cerebral Oxygen Desaturations Greater That 10% of Baseline Values Using NIRS in the ICU (NIRS-ICU)
A Pilot Trial to Assess the Feasibility and Efficacy of Treating Post-Cardiac Surgery Cerebral Desaturation in the Intensive Care Unit
Study objectives: The main objective of this study is to determine the feasibility of implementing measures in the intensive care unit (ICU), based on a physiological algorithm, to reverse decreases in cerebral oxygen saturation using, near-infrared spectroscopy (NIRS).
Methods: Randomization of 50 patients is balanced by experimental group; control and intervention, with an allocation sequence based on a block size of ten, generated with a computer random number generator. In the intervention group ICU Staff will use NIRS to follow a physiologically guided strategy to maintain regional oxygen saturation (rSO2) within 90% of baseline values. In the control group ICU Staff will provide standard of care without the use of NIRS.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and Rationale: Cerebral desaturation has previously been shown to be associated with significant morbidity in cardiac surgery postoperatively. As such, previously reported efforts have been aimed at treating intraoperative desaturation events, with early evidence suggesting that this may reduce the incidence of these adverse events. Our previous study, NIRS ICU (B2011:110) has demonstrated that significant cerebral oxygen desaturation [measured using near infrared spectroscopy (NIRS) derived cerebral oximetry] frequently occurs in the intensive care unit (ICU) within the first 24 hours following cardiac surgery. To date, no studies have addressed the early postoperative period (i.e. in the ICU) with respect to treating (and/or preventing) these desaturation events.
Specific Aims and Experimental Design: The specific aim of this pilot prospective interventional trial is to determine the feasibility/efficacy of treating cerebral oxygen desaturation in the ICU following cardiac surgery. Two groups of patients will be studied. Both groups will have cerebral saturation measured continuously both intraoperatively and postoperatively. The control group however, will have these measurements blinded to the intraoperative and postoperative caregivers. The interventional group will have the cerebral oximetry measurements available to the intraoperative and postoperative care team allowing them to intervene when a desaturation event occurs. If a cerebral desaturation occurs, defined as a decline in saturation of 10% from the patient's preoperative baseline, then a previously utilized interventional algorithm, normal cerebral oxygen saturation (NORMOSAT) (B2012:005), will be instituted to reverse the decrease in cerebral saturation, ideally preventing it from becoming a clinically meaningful desaturation (previously defined by others as saturation decline of 25% from the baseline). The algorithm used addresses many of the known causes of desaturation, including low arterial oxygen content (both saturation and hemoglobin) and cardiac output influences on cerebral blood flow. As such, if a desaturation occurs, the patient will first have the partial pressure of oxygen (PaO2) increased by increasing the inspired oxygen content. The partial pressure of carbon dioxide (PaCO2) will also be normalized by adjusting the ventilator settings. The cardiac output will be optimized and the blood pressure will be increased with standard ICU protocols to administer phenylephrine. If remaining low, the patients will be transfused to standard of care hemoglobin levels.
In this pilot trial, a convenience sample of 50 consecutive consenting patients undergoing cardiac surgery employing cardiopulmonary bypass (CPB) will be studied. After obtaining consent, bilateral cerebral oximetry sensors will be placed on the forehead of patients prior to the induction of anesthesia. Baseline (breathing room air) regional cerebral saturation will be recorded. Following this, induction of anesthesia will occur and continuous NIRS measurements will be collected during the surgical procedure with continued monitoring occurring for the first 24 hours (or until discharge) within the ICU. In the control group, conventional anesthesia and ICU standards of care will be carried out throughout the study period. In the interventional group, an algorithm based on the modification of previously defined important physiologic variables will be initiated to reverse the desaturation (beginning when the saturation drops at least 10% from the baseline) that occurs in the operating room (OR) and ICU.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2H 2A6
- St. Boniface Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients undergoing cardiac surgery employing CPB
Exclusion Criteria:
- patients having surgeries involving the aorta, or employing deep hypothermic circulatory arrest (DHCA)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: NIRS derived cerebral oximetry
NIRS derived cerebral oximetry device used but data not visable to ICU caregivers
|
NIRS sensors will be placed the forehead of the patient but NIRS derived data will be blinded to the ICU caregivers
Other Names:
|
Active Comparator: NIRS and Algorithm
NIRS derived cerebral oximetry device used and the caregiver in the ICU will see the data in order to guide the use of the interventional algorithm to treat the cerebral desaturation
|
NIRS sensors will be placed the forehead of the patient but NIRS derived data will be blinded to the ICU caregivers
Other Names:
NIRS cerebral oximetry will be used to guide the use of an algorithm based on the modification of previously defined important physiologic variables will be initiated to reverse the desaturation (beginning when the saturation drops at least 10% from the baseline) that occur in the ICU
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The incidence in the two groups of postoperative cerebral desaturation
Time Frame: 24 hours or unit discharge, which ever occurs first.
|
Following the end of the 24 hour time period, the NIRS data will be downloaded and analyzed to determine the incidence in the two groups of postoperative cerebral desaturation, primarily defined by a relative reduction in the rSO2 more than 25% from the baseline pre-anesthesia induction.
Furthermore, to determine the overall severity of desaturation, the area under the curve (AUC) for a desaturation less than the previously defined 75% of the baseline will be determined.
In addition to assessments of endothelial function and delirium, additional patient data on any adverse events will be collected by reviewing the patient charts as well as by phone interview on post-operation day 30.
|
24 hours or unit discharge, which ever occurs first.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hillary P Grocott, MD, Professor Department of Anesthesia and Surgery University of Manitoba
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B2012:118
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Ischemia
-
Icahn School of Medicine at Mount SinaiCompletedSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral VasospasmUnited States
-
Assiut UniversityCompletedSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral VasospasmEgypt
-
Egyptian Cerebro-Cardio-Vascular AssociationUnknownRisk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
-
Nova Scotia Health AuthorityActive, not recruitingSubarachnoid Hemorrhage | Delayed Cerebral Ischemia | Cerebral Vasospasm | CT PerfusionCanada
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
NoNO Inc.University of British Columbia; University of Toronto; University of Calgary; Genome... and other collaboratorsCompletedAcute Cerebral IschemiaCanada
-
Medical University of ViennaUniversity of Vienna; Austrian Science Fund (FWF)RecruitingSubarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Vasospasm, CerebralAustria
-
Pharmazz, Inc.RecruitingAcute Cerebral IschemiaIndia
-
El Instituto Nacional de Neurologia y Neurocirugia...CompletedBrain Ischemia | Subarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralMexico
-
Oregon Health and Science UniversityGlaxoSmithKline; Foundation for Anesthesia Education and ResearchCompletedEndothelial Dysfunction | Subarachnoid Hemorrhage, Aneurysmal | Delayed Cerebral Ischemia | Vasospasm, CerebralUnited States
Clinical Trials on NIRS derived cerebral oximetry
-
Clinical Hospital Centre ZagrebCompletedCarotid Stenosis | Postoperative Cognitive Dysfunction | Neurological ImpairmentCroatia
-
Copenhagen University Hospital, HvidovreThe Ludvig & Sara Elsass FoundationCompletedCerebral OxygenationDenmark
-
University of ManitobaNot yet recruiting
-
Dhritiman ChakrabartiCompletedCerebral Venous ThrombosisIndia
-
Maisonneuve-Rosemont HospitalUniversité de MontréalCompletedPlacental OxygenationCanada
-
Aristotle University Of ThessalonikiRecruitingCoronary Artery Disease | Aortic Valve Stenosis | Mitral DiseaseGreece
-
Gorm GreisenCompleted
-
University Hospital Inselspital, BerneCompletedHealthy | AdultsSwitzerland
-
Kasr El Aini HospitalCompletedHyperventilation | Infratentorial Neoplasms | CraniotomyEgypt
-
Wayne State UniversityUnknownEmergencies | Cardiac Arrest | Cardiac DeathUnited States